About
Why this site exists
Families of children with neurological conditions are approached constantly with regenerative treatments. They are rarely given the one thing that would let them decide well: a plain account of how strong the evidence is, written by someone with nothing to sell them.
How the grading works
Every statement is placed on a four-level scale — approved, in clinical trials, early research only, not supported — and the level is given per condition, not per therapy. A treatment that is licensed for one problem and untested for another is shown as exactly that. The scale and what each level means is set out on Judging a therapy.
What is deliberately absent
- No patient testimonials, before-and-after videos or success stories. They are the least reliable evidence in this field and the most persuasive.
- No referrals and no treatment bookings.
- No claim that a treatment works when the honest answer is that nobody has shown it.
Limits
This is general information, not advice about your child. It cannot account for your child's diagnosis, severity, medication or history, and it does not replace the clinician who does. Evidence in this field moves; where a page is out of date, the fault is ours and we would rather know.
Before agreeing to anything, write down what would count as improvement, how it will be measured, and the date you will review it — and keep your child’s existing therapy going regardless.
Author
Prof. Dr. Burak Tatlı
Professor of Paediatrics · Paediatric Neurology and Developmental Paediatrics
He read medicine at İstanbul University Cerrahpaşa Faculty of Medicine, then completed his paediatrics residency and served as chief resident in paediatric neurology at İstanbul University İstanbul Faculty of Medicine (Çapa) — one of the busiest academic centres in the country — where he also completed sub-specialty training in paediatric neurology and developmental paediatrics and went on to hold a faculty post. He became Associate Professor in 2006 and Professor in 2013, and has worked in independent practice since 2017, across a career now spanning three decades.
His clinical and research work centres on childhood epilepsy and drug-resistant epilepsy, on fetal and newborn neurology, and on identifying the at-risk infant early enough for it to matter. Cerebral palsy and spasticity, autism, and headache in childhood are his other principal areas.
- 30+ years in paediatric neurology
- 70+ international papers indexed in PubMed
- 8 books — three in English, five in Turkish
- Dozens of book chapters as author
Google Scholar, October 2026 — the live figures are on the profile below.
ORCID 0000-0003-1352-5917 ↗Google Scholar ↗PubMed ↗Wikidata ↗buraktatli.com ↗
Information only — it does not replace assessment by the doctor who looks after your child.